Dr. Ali Ghanem

Ali is a Business Analyst in TCS’ Life Sciences Consulting Practice based in Frankfurt, Germany. He currently supports digitalization projects of major German pharmaceutical clients in the clinical development domain.

Ali is a trained pharmacist and scientist. He received his Ph.D. from the University of Heidelberg in 2018 for his research on targeting the vulnerabilities in cancer cell metabolism. Afterwards he obtained his post-doctoral training at University Hospital Heidelberg focusing on viral vectors for precision gene therapy.

With his multifaceted research experience, Ali approaches consulting from an innovative perspective and is very passionate about identifying novel opportunities to respond to the rapidly evolving needs of TCS’ pharma partners.